Cheng Zhang

RAS signaling and remodeling of the immune microenvironment in pancreatic ductal adenocarcinoma: implications of emerging RAS-targeted therapy

This framework highlights the rationale for combining RAS inhibitors with immunotherapy and other microenvironment-targeted treatments and integrates RAS-driven stromal and immune remodeling with emerging allele-specific and multi-selective RAS therapies.